NCT03029533View on ClinicalTrials.gov

Phase 1 Study to Evaluate the Pharmacokinetics and Safety Following SC Administration of DWJ108J in Patients With Prostate Cancer

PHASE1UnknownINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

February 28, 2017

Primary Completion Date

November 30, 2017

Conditions
Prostate Cancer
Interventions
DRUG

Leuprolide Acetate

DWJ108J, SC injection, once(Day1)

DRUG

Leuprolide Acetate

Leuplin DPS Inj, SC injection, once(Day1)

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY